IGM Biosciences Stock Quote IGMS - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

16.005

Bid

15.84

Ask

16.17

Volume

227,812

15.57 Day's Range 16.39

3.81 52 Week Range 22.50

Market Cap

949.395M

Previous Close

16.16

Open

16.37

Last Trade

100

16.005

Last Trade Time

12:52:29

Financial Volume

$ 3,635,924

VWAP

15.9602

Average Volume (3m)

309,297

Shares Outstanding

59,318,669

Dividend Yield

PE Ratio

-3.83

Earnings Per Share (EPS)

-4.15

Revenue

2.13M

Net Profit

-246.42M

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking ago... IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.igmbio.com

Headquarters

Dover, Delaware, USA

Founded

IGM Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IGMS. The last closing price for IGM Biosciences was $16.16. Over the last year, IGM Biosciences shares have traded in a share price range of $ 3.81 to $ 22.50.

IGM Biosciences currently has 59,318,669 shares outstanding. The market capitalization of IGM Biosciences is $958.59 million. IGM Biosciences has a price to earnings ratio (PE ratio) of -3.83.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	3.4701	27.6835076467	12.5349	22.5	12.35	839230	17.08700848	CS
4	5.485	52.13878327	10.52	22.5	9.18	327937	14.96688867	CS
12	9.155	133.649635036	6.85	22.5	6.1721	309297	11.76257753	CS
26	5.655	54.6376811594	10.35	22.5	6.1721	319691	10.16487787	CS
52	8.745	120.454545455	7.26	22.5	3.81	318093	9.36243103	CS
156	-58.685	-78.5714285714	74.69	76.2	3.81	352663	18.6770639	CS
260	-5.505	-25.5927475593	21.51	133	3.81	276338	30.42043498	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
KAVLKaival Brands Innovations Group Inc	$ 1.4401 (148.72%)	153.99M
LASELaser Photonics Corporation	$ 17.423 (67.37%)	7.37M
TGLTreasure Global Inc	$ 1.12 (64.63%)	128.8M
NVVENuvve Holding Corporation	$ 5.89 (50.26%)	27.71M
UXINUxin Ltd	$ 2.37 (49.53%)	11.72M
ELABElevai Labs Inc	$ 0.1109 (-60.39%)	13.33M
ADTXAditxt Inc	$ 0.269 (-29.69%)	2.05M
FRGTFreight Technologies Inc	$ 0.0805 (-29.26%)	21.84M
ZJYLJin Medical International Ltd	$ 2.8901 (-29.16%)	726.53k
ANEBAnebulo Pharmaceuticals Inc	$ 2.34 (-24.03%)	89.04k
XPONExpion360 Inc	$ 0.107631 (26.92%)	364.45M
KAVLKaival Brands Innovations Group Inc	$ 1.4401 (148.72%)	153.99M
TGLTreasure Global Inc	$ 1.12 (64.63%)	128.8M
NVDANVIDIA Corporation	$ 115.56 (-0.38%)	119.51M
INTCIntel Corporation	$ 22.5499 (3.25%)	111.84M